PEDE - August 19, 2009 - (Page 4) Sweden takes the reins The presence of a high-flying Obama administration insider at the upcoming Swedish life sciences summit is just one indication of the seriousness with which the country taking its EU presidency. S weden is showing it means business with its current presidency of the EU — and raising hopes among European pharmaceutical executives of some effective action between now and December. Health had already been allocated a prominent place on Sweden’s agenda when it took over the rotating six-month presidency of the EU at the start of July. But hopes have risen further with the news that Diana DeGette has been attracted to address the SwedishAmerican Life Science Summit (SALSS) in Stockholm in August. DeGette, Democrat Representative for Colorado, US, is a top Obama advisor on healthcare reform, with a strongly pro-technology profile. Notably, she was co-sponsor of the pioneering Stem Cell Research Enhancement Act in 2007 — the legislation twice vetoed by George Bush — and author of Sex, Science, and Stem Cells: Inside the Right Wing Assault on Reason, a no-holds-barred exposé of the how right-wing America has politicised sex, science and reproductive health. Radical thinking The organisers have declared that, coinciding with the new US President’s determination to push for profound reform in healthcare provision in the world’s largest economy, the meeting aims to catalyse radical thinking on what will make for better provision — and better business — worldwide. Barbro Ehnbom, who is chairing the conference — and whose background goes back as far as Smith Kline and American Home Products — sees a watershed moment: “The healthcare world has changed. The rules have changed,” she says. “Although the US continues to be at the centre of the life sciences economy, many of the previous tenets we took for granted have changed… The focus is not simply on how we finance innovation and drug development but also on how we reach the market”. She champions Sweden is having to pilot the EU through what are arguably the most difficult six months the Union has faced since it came into existence. She will be setting the tone for a meeting featuring other big names in life sciences bidding for a sharper, more business-oriented approach to healthcare, including Dr. Anders Ekblom, executive vice president, AstraZeneca, Dr Mikael Dolsten, president, Biotechnology R&D, Pfizer-Wyeth, and Dr Paul Bolno, vice president, GlaxoSmithKline. technology as “a vital driver”. Sweden is having to pilot the EU through what are arguably the most difficult six months the Union has faced since it came into existence. Against the background of the economic and financial crisis, and in the face of the tough choices that will have to be made before the world summit on climate change in Copenhagen in December, the EU is drifting without agreement on its constitution or on who should lead it over the next five years. Despite that, the Swedish government is working hard to secure EU-level agreements on how to fight counterfeit drugs, how to improve patent protection, and how to sharpen boost research policy — including on preventive measures against pandemics, and on tackling the growing problem of antibiotic resistance. The life sciences discussions in August should impart some valuable momentum to its efforts. 2 NEWS 4 11 SWEDEN LEADS THE EU LAST WORDS 5 NON-EXECUTIVE SEARCH 8 PATENT DISPUTES 10 CALENDAR SUBSCRIBE TO PHARM EXEC DIGEST EUROPE Stockbyte/Getty Images http://books.google.com/books?id=YM6dJBVPYVYC&printsec=frontcover&dq=sex,+science+and+stem+cells#v=onepage&q=&f=false http://books.google.com/books?id=YM6dJBVPYVYC&printsec=frontcover&dq=sex,+science+and+stem+cells#v=onepage&q=&f=false http://books.google.com/books?id=YM6dJBVPYVYC&printsec=frontcover&dq=sex,+science+and+stem+cells#v=onepage&q=&f=false http://www.swedishamericanlifescience.com http://www.swedishamericanlifescience.com http://pharmexec.findpharma.com/pharmexec/newsletter/subscribeNewsletter.jsp Table of Contents for the Digital Edition of PEDE - August 19, 2009 PEDE - August 19, 2009 Contents News Brussels Report Executive Recruitment Patent Disputes Event Focus Last Words PEDE - August 19, 2009 PEDE - August 19, 2009 - Contents (Page 1) PEDE - August 19, 2009 - News (Page 2) PEDE - August 19, 2009 - News (Page 3) PEDE - August 19, 2009 - Brussels Report (Page 4) PEDE - August 19, 2009 - Executive Recruitment (Page 5) PEDE - August 19, 2009 - Executive Recruitment (Page 6) PEDE - August 19, 2009 - Executive Recruitment (Page 7) PEDE - August 19, 2009 - Patent Disputes (Page 8) PEDE - August 19, 2009 - Patent Disputes (Page 9) PEDE - August 19, 2009 - Event Focus (Page 10) PEDE - August 19, 2009 - Last Words (Page 11) PEDE - August 19, 2009 - Last Words (Page 12) http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201302 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201301 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201212 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201211 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201210 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201209 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201208 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201207 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201206 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201205 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201204 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201203 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201202 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201201 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201112 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201111 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201110 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201109 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110823 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110809 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110728_v2 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110728 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110711 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110624 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110609 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110526 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110512 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_oracle_201105 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110426 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110412 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110324 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110310 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110224 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110208 http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110128 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_mediakit2011 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101216 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101124 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101111 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101027 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101013 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100930 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100915_supp http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100915 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100825 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100811 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100727 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100713 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100623 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100609 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100526 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100512 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_ims_201005 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100427 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100414 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100324 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100310 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100224 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100210 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100126 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100112 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091222 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091208 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091124 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091110 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091027 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091013 http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_DIGEST_20090930 http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_digest_20090916 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090902 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090825 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090819 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090812 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090805 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090729 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090721 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090715 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090708 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090701 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090624 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090617 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090610 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090602 http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090526 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090519 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090512 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090505 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_southafrica http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090429 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090422 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090415 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090408 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401_v2 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090325 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090318 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090311 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090304 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090224 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090218 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090211 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090203 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090128 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090121 http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090114 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1208 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1108 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1008 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1008 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0908 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0808 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0708 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0608 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0508 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0508 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0408 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0308 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0208 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0208 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0108 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1207 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1107 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1007 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imsoncology0907 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0407 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0307 http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1206 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.